Őž√ņīę√Ĺ

Our News on Newswise

Newswise: 667430cc5e9da_RonaldDePinho.jpg

Activating molecular target reverses multiple hallmarks of aging

Researchers at The University of Texas MD Anderson Cancer Center have demonstrated that therapeutically restoring ‚Äėyouthful‚Äô levels of a specific subunit of the telomerase enzyme can significantly reduce the signs and symptoms of aging in...
20-Jun-2024 10:00 AM EDT Add to Favorites

CAR NK cells with CD28 costimulation improved cell persistence and antitumor activity

Adding CD28 costimulation to cord blood-derived chimeric antigen receptor (CAR) natural killer (NK) cells targeting CD70+ cancers significantly enhanced antitumor efficacy and long-term cytotoxicity of the CAR NK cells, according to researchers from...
19-Jun-2024 11:05 AM EDT Add to Favorites

MD Anderson Research Highlights for June 19, 2024

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s...
19-Jun-2024 12:00 PM EDT Add to Favorites

MD Anderson’s Institute for Data Science in Oncology establishes internal advisory council to maximize impact

The Institute for Data Science in Oncology (IDSO) at The University of Texas MD Anderson Cancer Center today announced the establishment of its internal advisory council to identify needs and opportunities for data science development and...
18-Jun-2024 10:05 AM EDT Add to Favorites

MD Anderson Research Highlights: EHA 2024 Special Edition

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research, and prevention. These advances are made possible through seamless collaboration between MD Anderson’s...
13-Jun-2024 10:00 AM EDT Add to Favorites

MD Anderson and Sibylla Biotech announce strategic collaboration to discover and develop small-molecule protein degraders

The University of Texas MD Anderson Cancer Center and Sibylla Biotech today announced a strategic collaboration agreement to discover and develop novel small-molecule cancer therapies known as folding interfering degraders (FIDs), which disrupt the...
12-Jun-2024 8:00 AM EDT Add to Favorites

MD Anderson Research Highlights for June 5, 2024

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s...
5-Jun-2024 12:00 PM EDT Add to Favorites

Newswise: steven_frank.jpg.resize.405.575.high.jpg

ASCO: Proton therapy demonstrates advantages in Phase III head and neck cancer trial

According to preliminary data from a multi-institution Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, intensity modulated proton therapy (IMPT) achieved similar clinical outcomes and offered significant...
3-Jun-2024 8:05 AM EDT Add to Favorites


See All News

Our Experts on Newswise

Newswise: BenjaminSmith.jpg

Mastectomy Plus Reconstruction Has Highest Rate of Complication, Complication-Related Costs of Guideline-Concordant Therapies for Early Breast Cancer

In a review of guideline-concordant treatment modalities for women with early stage breast cancer, mastectomy and reconstruction had the highest rate of complications and complication-related costs, regardless of age.
27-Sep-2016 3:05 PM EDT

Newswise: Liang_H_Bronto.jpg

Can Gender Play a Role in Determining Cancer Treatment Choices?

It is well known that men and women differ in terms of cancer susceptibility, survival and mortality, but exactly why this occurs at a molecular level has been poorly understood.
9-May-2016 12:00 PM EDT

Newswise: ZhiminLu.jpg

MD Anderson Study Reveals New Insight Into Tumor Progression

Scientists know that activation of growth factor receptors like epidermal growth factor receptors (EGFR) promote tumor progression in many types of cancer.
17-Aug-2015 11:00 AM EDT

Newswise: Lee_M.jpg

Poor Survival Among Colorectal Cancer Patients Tied to Biomarker CSN6

A protein called CSN6 has been found to be correlated with poor survival among patients with colorectal cancer, according to a study at The University of Texas MD Anderson Cancer Center.
10-Aug-2015 12:00 PM EDT

Newswise: 204929_Chhatwal_Jjpg.jpg

MD Anderson Study Predicts New Hepatitis C Drugs Will Place a Dramatic Financial Strain on the Health Care System

The cost of treating people infected with the hepatitis C virus (HCV) with newly approved therapies will likely place a tremendous economic burden on the country’s health care system. The prediction comes from a cost-effectiveness analysis led by...
16-Mar-2015 6:00 PM EDT

MD Anderson Joins CATCH Global Foundation to Boost Child Health, Prevent Cancer in Later Years

Cancer prevention experts at The University of Texas MD Anderson Cancer Center have allied with the CATCH Global Foundation, whose comprehensive child health program reaches children and their families in more than 10,000 educational settings...
18-Feb-2015 10:00 AM EST

See All Experts

Our YouTube Videos

About

The University of Texas MD Anderson Cancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevention. The institution‚Äôs sole mission is to end cancer for patients and their families around the world, and, in 1971, it became one of the nation‚Äôs first National Cancer Institute (NCI)-designated comprehensive cancer centers. MD Anderson is No. 1 for cancer in U.S. News & World Report‚Äôs ‚ÄúBest Hospitals‚ÄĚ rankings and has been named one of the nation‚Äôs top two hospitals for cancer since the rankings began in 1990. MD Anderson receives a cancer center support grant from the NCI of the National Institutes of Health (P30 CA016672).

Experts

Contacts

McKenna Bauer
Communications Specialist - Public Relations

MMBauer@mdanderson.org

Aubrey Bloom
Program Manager, Public Relations

ARBloom@mdanderson.org

830-377-8566

Clayton Boldt
Program Director, Public Relations

CRBoldt@MDAnderson.org

713-792-9518

Andrea Bolt
Sr. Communications Specialist

ARBolt@MDAnderson.org

Lany Kimmons
Program Manager, Public Relations

rlkimmons@mdanderson.org

713-563-5801

Jamie Mauracher
Program Manager

JRMauracher@MDAnderson.org

Julie Nagy
Program Manager, Public Relations

jenagy@mdanderson.org

713-563-3437

Rosalina Nieves
Program Manager, Communications

RNieves1@mdanderson.org

346-834-0365

Elise Raymund
Sr. Communication Specialist

ERRaymund@mdanderson.org

346-725-0943

Allison Schaffer
Program Manager, Public Relations

ASchaffer@mdanderson.org

713-745-1357

Jade Waddy
Program Manager, Public Relations

JAWaddy@mdanderson.org

346-725-2126

Twitter

Facebook

close
1.35227